Approval for expanded patient use significantly increased its addressable market and revenue projections.
: The best-performing stock on the Dow Jones Industrial Average , closing up 89% . top companies to buy stock in 2017
: Rose 103% following major breakthroughs in cystic fibrosis treatments. The company saw record-breaking sales and profit growth
The company saw record-breaking sales and profit growth as demand for transparent orthodontics surged globally. Success was driven by a major corporate transformation
Commercial jet demand reached such highs that the company's 737 narrow-body planes were effectively sold out for the following decade. 2017 Return Primary Growth Driver NRG Energy Corporate restructuring & debt reduction Align Technology Global Invisalign expansion Vertex Pharmaceuticals Cystic fibrosis drug breakthroughs Wynn Resorts Recovery of the Macau gambling market Boeing Surge in commercial aircraft deliveries Micron Technology High demand for DRAM and NAND memory PayPal Holdings Boom in e-commerce and mobile payments The 25 Top-Performing S&P 500 Stocks of 2017
: Gained 131% as its Invisalign product dominated the clear aligner market.
Success was driven by a major corporate transformation plan focusing on asset sales and massive debt reduction.